Cite
APA Citation
Shien, T., Shimomura, A., Uemura, Y., Kato, H., Kitada, M., Kikawa, Y., Shiba, E., Yoshida, T., Morimoto, T., Toyama, T., Aihara, T., & Mukai, H. (n.d.). 313TiPOpen-label phase II study of everolimus plus endocrine therapy in post-menopausal women with ER+, HER2- metastatic breast cancer (Chloe trial). Annals of oncology, 28, . http://access.bl.uk/ark:/81055/vdc_100097079069.0x000031